RT2019.gif

China Daily

News> Nation> Content
Thursday, March 14, 2019, 17:25
China to add more cancer drugs on medical insurance list
By Xinhua
Thursday, March 14, 2019, 17:25 By Xinhua

Pharmacists work at a hospital in Nanning, Guangxi Zhuang autonomous region. (LU BOAN / XINHUA)

BEIJING — China is considering adding more anti-cancer drugs to its list of medicines eligible for medical insurance reimbursement, in an effort to reduce the burden on patients. 

In October 2018, 17 anti-cancer drugs were included in China's medical insurance reimbursement list

Apart from cancer drugs, medicines for rare diseases, chronic illness, children and first-aid treatment are among the options for a lengthened reimbursement list, the National Healthcare Security Administration (NHSA) said in a document aimed at expanding medical insurance coverage. 

READ MORE: China to speed up launch of new cancer drugs

The candidates for inclusion should be drugs that have been launched in markets with the approval of the National Medical Products Administration before Dec 31, 2018, said the document. 

The existing medicines for reimbursement that have been banned from production, sales and use by national drug regulators should be excluded from the list, said the document, with a new list to be released in June 2019. 

ALSO READ: 17 cancer drugs added to insurance program list

In October 2018, 17 anti-cancer drugs were included in China's medical insurance reimbursement list, with their prices cut by 56.7 percent on average after a round of price negotiations between the NHSA and pharmaceutical companies. 


Share this story

CHINA DAILY
HONG KONG NEWS
OPEN
Please click in the upper right corner to open it in your browser !